Payers are stepping up efforts to manage the cost and utilization of orphan drug treatments.
The cost to treat cancer in the United States could reach $156 billion in 2020, according to the National Cancer Institute. And innovative medications have a significant impact on the cost of care.
Expiring patents and biosimilar developments are creating big market opportunities within the specialty drug space.
In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
More targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
Prepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD.
Autologous stem cell therapy may offer hope for patients with COPD. But some say caution is necessary.
CAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.
Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.
Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.